Greenspring Associates’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,573,357
| Closed | -$31M | – | 12 |
|
|
2021
Q2 | $31M | Hold |
1,573,357
| – | – | 2.1% | 5 |
|
|
2021
Q1 | $45.7M | Hold |
1,573,357
| – | – | 36.38% | 1 |
|
|
2020
Q4 | $47.7M | Hold |
1,573,357
| – | – | 61.89% | 1 |
|
|
2020
Q3 | $25M | Hold |
1,573,357
| – | – | 38.95% | 1 |
|
|
2020
Q2 | $31.1M | Hold |
1,573,357
| – | – | 19.06% | 2 |
|
|
2020
Q1 | $19.4M | Hold |
1,573,357
| – | – | 8.03% | 4 |
|
|
2019
Q4 | $29.1M | Hold |
1,573,357
| – | – | 7.67% | 5 |
|
|
2019
Q3 | $21.8M | Hold |
1,573,357
| – | – | 6.61% | 5 |
|
|
2019
Q2 | $23M | Buy |
+1,573,357
| New | +$23M | 11.86% | 2 |
|